Sanofi’s strength in molecular oncology is likely to provide it a competitive edge over its peers as to what drives the growth of cancer tissues, how these cells functions and proliferation in the body. In a strategic development, French drugmaker,… Read More ›
By targeting U.S. crude, Beijing has placed the Trump administration’s “energy dominance” in its cross-hairs. In a development that adds to pressure on the U.S. government to scale back trade pressures on China, energy analysts and executives have disclosed the… Read More ›
The shifting sands of the Dow are testament to the companies that were once perceived as unassailable household names before falling victims to an evolving economy. An original member of the S&P Dow Jones Indices, General Electric Co has lost… Read More ›
manageria.biz 